IBB
$217.75iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense ratio
0.44%
Dividend yield
0.16%
AUM
$11.50B
Issuer
iShares
YTD return
30.22%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · IBB
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
Sector exposure
Sector breakdown · IBB
Healthcare100.0%